TIDMCPT
RNS Number : 0722F
Concepta PLC
16 February 2018
16 February 2018
Concepta plc
("Concepta" or the "Company")
Concepta Announces Two Senior Appointments and Grant of
Options
Concepta plc (AIM: CPT) the UK healthcare company and developer
of a proprietary product targeted at the mobile health market with
a primary focus on women's fertility, is pleased to announce the
appointment of David Darrock, Chief Operating Officer of the
Concepta group, as a director of Concepta Diagnostics Ltd.
David joined Concepta in October 2017 as Site Director for our
Doncaster operation. He has significant experience managing Chinese
supply chains, so in addition to managing the Company's
manufacturing site in Doncaster, David will also be heading the
supply chain management process to ensure volume requirements are
met as the Company scales its operations.
In view of his promotion, on 15 February 2018, David Darrock has
been granted share options ("Options") to subscribe for up to
1,000,000 ordinary shares of 2.5 pence each in the capital of the
Company ("Ordinary Shares") as follows:
Name Title Number Total number % of existing
of Options of Options issued
granted held following share capital
the grant represented
by the
total Options
held
--------------- ----------------- ------------ ---------------- ---------------
Chief Operating
David Darrock Officer 1,000,000 1,000,000 0.72%
--------------- ----------------- ------------ ---------------- ---------------
The options are exercisable in three equal tranches over the
three-year period from the date of grant, pursuant to the rules of
the Company's Share Option Plan. The options have an exercise price
of 5.95 pence per share, being the closing mid-market price of the
Company's Ordinary Shares at 14 February 2018.
Alongside David's appointment, and to strengthen the China team,
Michelle Yao has been appointed as China General Manager, and will
be reporting to Zhang Zi Gang, the UK-based Head of China.
Michelle has previously worked for Alere in China as Marketing
Manager and recently ran her own company in the medical diagnostic
device sector. She will lead the China operational team and work
with distributors, logistics and marketing operations to support
the market penetration of the MyLotus products in China.
Erik Henau, CEO of Concepta stated: "On behalf of the Board, I
am delighted to announce these two senior appointments.
"David joined us in October last year and in a short period, he
has made an invaluable contribution to the advancement of our
operations from small batch laboratory-based production to
industrial manufacturing scale. He has played a pivotal role in
streamlining the supply chain, to ensure the effective delivery of
our products to our customers, and we are delighted to welcome him
to the Board of Concepta Diagnostics Ltd.
"Additionally, Michelle's experience and market knowledge will
not only be essential in ensuring an effective launch of myLotus in
China to augment market awareness, but also in maintaining the
ongoing marketing operations thereafter. We are thrilled that
Michelle has joined Concepta and we are very much looking forward
to working alongside her."
1 Details of the person discharging managerial responsibilities/person closely associated
--- -----------------------------------------------------------------------------------------------------------
a) Name David Darrock
--- ------------------------------------------------------------ ---------------------------------------------
2 Reason for the notification
--- -----------------------------------------------------------------------------------------------------------
a) Position/status Chief Operating Officer
(PDMR)
--- ------------------------------------------------------------ ---------------------------------------------
b) Initial notification/Amendment Initial notification
--- ------------------------------------------------------------ ---------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------------------------------------------------------
a) Name Concepta plc
--- ------------------------------------------------------------ ---------------------------------------------
b) LEI 213800RBHY6LZDG13168
--- ------------------------------------------------------------ ---------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--- -----------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Concepta plc Shares
Identification code
--- ------------------------------------------------------------ ---------------------------------------------
b) Nature of the transaction Grant of Options over Ordinary Shares
--- ------------------------------------------------------------ ---------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
------------------------------- ----------
Grant of options at GBP0.0595 1,000,000
------------------------------- ----------
--- ------------------------------------------------------------ ---------------------------------------------
d) Aggregated information - Aggregated volume
------------------
- Price
------------------
--- ------------------------------------------------------------ ---------------------------------------------
e) Date of the transaction 15-02-2018
--- ------------------------------------------------------------ ---------------------------------------------
f) Place of the transaction
--- ------------------------------------------------------------ ---------------------------------------------
Enquiries:
The Company
Erik Henau
CEO
Tel: +44 (0) 1234 866601
SPARK Advisory Partners Limited (Nomad)
Neil Baldwin / Andrew Emmott
Tel: +44 (0)20 368 3550
NOVUM Securities Limited (Broker)
Colin Rowbury
+44 (0) 20 7399 9400
Yellow Jersey (Financial PR)
Georgia Colkin / Joe Burgess / Katie Bairsto
Tel: +44 (0) 776 932 5254
About Concepta Plc:
Concepta plc is an AIM-quoted pioneering UK healthcare company
that has developed a proprietary product, myLotus, targeted at the
personalised mobile health market with a primary focus on
unexplained infertility* in women.
myLotus is currently the only consumer product which allows both
quantitative and qualitative measurements of a woman's personal LH
and hCG* hormone levels in a home test, facilitating higher
conception rates and early diagnosis of issues with fertility
hormones. The proposition of myLotus is to help women conceive
naturally.
Concepta has made significant progress recently, establishing
agreements with a number of distributors in China where myLotus has
been given cFDA approval. Concepta is initially targeting the
traditional route to market in China through Chinese hospitals and
plans to add the direct-to-consumer route in the near future.
The Company is also well on its way to achieving CE-marking and
commencing its direct-to-consumer launch in the UK and Europe in H1
2018. The Company has identified a significant global market
opportunity, with revenue potential of the Chinese and EU
unexplained infertility market estimated to be worth c.GBP600m per
annum.
*Unexplained infertility refers to women that have been unable
to conceive after 6 months of trying. This highly motivated target
group of consumers won't typically be offered medical intervention
until 12 months of unsuccessfully trying, with IVF not offered
until two years. Research indicates couples start to take positive
action ahead of this time and there is little medical support to
help them do so.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDBGDDISBBGIU
(END) Dow Jones Newswires
February 16, 2018 02:00 ET (07:00 GMT)
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Apr 2024 to May 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From May 2023 to May 2024